Events & Presentations Events & Presentations Upcoming Events There are no upcoming events scheduled at this time. Presentations Title Date Documents Corporate Presentation September 8, 2020 Add Files September 2020 1.5 MB ASBMR 2020 Annual Meeting Virtual Event September 11, 2020 Add Files KER-012, a Novel Activin Receptor Type II Ligand Trap Increased Bone in Mice via a Unique Mechanism of Action 1.5 MB 25th European Hematology Association (EHA) Congress (2020) June 12, 2020 Add Files Poster Presentation: Administration of KER-050, a Novel ActRIIA Ligand Trap, to Healthy Participants Elicited Robust and Sustained Increases in Hemoglobin and Platelets 1.3 MB Poster Presentation: KER-050, a Novel Modified ActRIIA Ligand Trap, Increases Red Blood Cell Production in Cynomolgus Monkeys 1.3 MB Poster Presentation: KER-050, a Novel Inhibitor of TGF-β Superfamily Signaling, Induces Red Blood Cell Production and is a Potential Candidate for the Treatment of Ineffective Erythropoiesis 1.1 MB Oral Presentation: Selective Inhibition of ALK2 Signaling Ameliorates Disease in a Novel Model of Iron Refractory Iron Deficiency Anemia (IRIDA) 2.5 MB
Events & Presentations Upcoming Events There are no upcoming events scheduled at this time. Presentations Title Date Documents Corporate Presentation September 8, 2020 Add Files September 2020 1.5 MB ASBMR 2020 Annual Meeting Virtual Event September 11, 2020 Add Files KER-012, a Novel Activin Receptor Type II Ligand Trap Increased Bone in Mice via a Unique Mechanism of Action 1.5 MB 25th European Hematology Association (EHA) Congress (2020) June 12, 2020 Add Files Poster Presentation: Administration of KER-050, a Novel ActRIIA Ligand Trap, to Healthy Participants Elicited Robust and Sustained Increases in Hemoglobin and Platelets 1.3 MB Poster Presentation: KER-050, a Novel Modified ActRIIA Ligand Trap, Increases Red Blood Cell Production in Cynomolgus Monkeys 1.3 MB Poster Presentation: KER-050, a Novel Inhibitor of TGF-β Superfamily Signaling, Induces Red Blood Cell Production and is a Potential Candidate for the Treatment of Ineffective Erythropoiesis 1.1 MB Oral Presentation: Selective Inhibition of ALK2 Signaling Ameliorates Disease in a Novel Model of Iron Refractory Iron Deficiency Anemia (IRIDA) 2.5 MB
